TORONTO, Nov. 30, 2011 /PRNewswire/ -- Platform Computing, today announced that Cancer Research UK, a world leader in the study of cancer, has turned to Platform LSF to help drive forward its human genome research project at the Cambridge Research Institute (CRI). Platform LSF is the most powerful workload manager available for high performance computing (HPC) environments and scientific computing. By integrating Platform LSF with a new advanced genetic sequencing platform, the institute has gained greater insight into genetic cancer mutations, that will lead to scientific breakthroughs in the areas of cancer diagnosis, treatment and prevention.
"Platform LSF gives us the means to produce and manage a wealth of gene sequencing data that we could only have dreamed about previously," said Peter Maccallum, head of IT and scientific computing at Cancer Research UK in Cambridge. "This has already lead to tangible published work looking into breast cancer, and is proving its worth in helping our researchers further the understanding of how cancers progress."
Prior to implementing Platform LSF, CRI's 21 research groups employed separate computing resources in separate locations, which drove up server costs, reduced utilization rates and increased server maintenance. By orchestrating workloads and managing CRI's research applications in a single data center, Platform LSF has enabled CRI to save approximately 50,000 pounds Sterling by removing hardware and maintenance duplication across each location, while increasing the amount of data processed. The institute can now direct more computing resources directly to its research teams to use in a more timely and cost efficient manner.
CRI has already saved the equivalent in man hours of one full-time employee by integrating Platform LSF. As a result, the institute plans to scale Platform LSF internally by adding more servers as compute requirements increase. CRI is also collaborating with Platform Computing to architecturally support cross-organization systems for HPC clusters that will enable CRI to collaborate with other research organizations in order to meet the growing demand for genomics research.
"CRI's new genomics research technology is a great scientific advancement that empowers biologists to better understand how genetic mutations evolve during the progression of cancer," said Christopher Nathan, Vice President Europe, Platform Computing. "We look forward to continuing our collaboration with CRI in accelerating insight by giving researchers the computational resources they need to fight for a cure."
About Platform Computing
Platform Computing is the leader in cluster, grid and cloud management software serving more than 2,000 of the world's most demanding organizations. For 19 years, our workload and resource management solutions have delivered IT responsiveness and lower costs for enterprise and HPC applications. Visit www.platform.com.
SOURCE Platform Computing